COMPANIESAKOYA BIOSCIENCES, INC.
✓ Verified H1B Sponsor

AKOYA BIOSCIENCES, INC.

Marlborough, MAEIN 475586242
TRUST SCORE
87.6
High Trust
7
FY2024 H1B Approvals
7
All-time Approvals
87.6
Trust Score / 100

TOP SPONSORED JOB CATEGORIES

Biochemists and BiophysicistsMedical Scientists, Except EpidemiologistsMarketing Managers

RECENT H1B FILINGS

JOB TITLELOCATIONWAGEDATE
Software DevelopersMarlborough, MA$177,154Dec 2025
Marketing ManagersMarlborough, MA$170,000Nov 2025
Bioengineers and Biomedical EngineersMarlborough, MA$84,918Oct 2025
Electrical EngineersMarlborough, MA$140,000Sep 2025
Computer and Information Research ScientistsMarlborough, MA$165,000May 2025
Biochemists and BiophysicistsMarlborough, MA$118,331Oct 2024
Biochemists and BiophysicistsMarlborough, MA$118,331Oct 2024
Medical Scientists, Except EpidemiologistsMarlborough, MA$140,000Oct 2024
Medical Scientists, Except EpidemiologistsMarlborough, MA$140,000Oct 2024

SHOWING 50 MOST RECENT · SOURCE: DOL LCA PUBLIC DATA FY2024 · EIN 475586242

FREQUENTLY ASKED QUESTIONS

Does AKOYA BIOSCIENCES, INC. sponsor H1B visas?

Yes. AKOYA BIOSCIENCES, INC. has an active H1B sponsorship history with 7 total approved LCA filings on record, including 7 approvals in FY2024. Data sourced from US Department of Labor public disclosure files.

How many H1B visas has AKOYA BIOSCIENCES, INC. sponsored?

According to DOL LCA data, AKOYA BIOSCIENCES, INC. has 7 all-time H1B approvals and 7 approvals in fiscal year 2024.

What types of roles does AKOYA BIOSCIENCES, INC. sponsor H1B for?

AKOYA BIOSCIENCES, INC. most commonly sponsors H1B visas for: Biochemists and Biophysicists, Medical Scientists, Except Epidemiologists, Marketing Managers. This is based on their DOL Labor Condition Application filing history.

Is AKOYA BIOSCIENCES, INC. a reliable H1B sponsor?

AKOYA BIOSCIENCES, INC. has a Trust Score of 87.6/100 on KEEL, calculated from total approval volume, recency of filings, and approval consistency based on DOL LCA data.

DATA SOURCE: US DEPT. OF LABOR · LCA PUBLIC DISCLOSURE FY2023–FY2024